A Non-Interventional Study of the Occurrence Rate of Non-Small Cell Lung Cancer, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey, and Diagnosis and Treatment Characteristics
NCT ID: NCT01775514
Last Updated: 2016-11-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
32277 participants
OBSERVATIONAL
2012-10-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Participants With Cancer
Participants from Turkey with non-small cell lung, colon cancer, breast cancer, gastric cancer and malignant melanoma will be included.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Participants who give consent to the collection of their information after the first record and pathological confirmation of their cancer
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Adana, , Turkey (Türkiye)
Adana, , Turkey (Türkiye)
Afyonkarahisar, , Turkey (Türkiye)
Ankara, , Turkey (Türkiye)
Ankara, , Turkey (Türkiye)
Ankara, , Turkey (Türkiye)
Ankara, , Turkey (Türkiye)
Ankara, , Turkey (Türkiye)
Baıkesir, , Turkey (Türkiye)
Bursa, , Turkey (Türkiye)
Bursa, , Turkey (Türkiye)
Denizli, , Turkey (Türkiye)
Diyarbakır, , Turkey (Türkiye)
Edirne, , Turkey (Türkiye)
Erzurum, , Turkey (Türkiye)
Gaziantep, , Turkey (Türkiye)
Isparta, , Turkey (Türkiye)
Istanbul, , Turkey (Türkiye)
Istanbul, , Turkey (Türkiye)
Istanbul, , Turkey (Türkiye)
Istanbul, , Turkey (Türkiye)
Istanbul, , Turkey (Türkiye)
Izmir, , Turkey (Türkiye)
Izmir, , Turkey (Türkiye)
Izmir, , Turkey (Türkiye)
Kayseri, , Turkey (Türkiye)
Konya, , Turkey (Türkiye)
Malatya, , Turkey (Türkiye)
Sıhhiye, Ankara, , Turkey (Türkiye)
Tokat Province, , Turkey (Türkiye)
Trabzon, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML28579
Identifier Type: -
Identifier Source: org_study_id